309. Optimization of Dual AAV Vectors for Gene Therapy of Inherited Retinal Diseases

Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33918-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

308. Inclusion of Heterologous ITRs in Dual AAV Vectors for Retinal Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2019English

310. Development of Generation X Recombinant AAV Vectors for Human Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2015English

410. pDMAEMA-Based Polyplexes as Vectors for Retinal Gene Therapy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Inherited Retinal Diseases in Dogs: Advances in Gene/Mutation Discovery

The Journal of Animal Genetics
2014English

Developing Immunologically Inert Adeno-Associated Virus (AAV) Vectors for Gene Therapy: Possibilities and Limitations

Current Pharmaceutical Biotechnology
BiotechnologyPharmaceutical Science
2014English

MERTK Mutations Update in Inherited Retinal Diseases

Human Mutation
Genetics
2018English

Engineered AAV Vectors for Improved Central Nervous System Gene Delivery

Neurogenesis
Developmental NeuroscienceDevelopmental Biology
2015English

Development of Foamy Virus Vectors for Gene Therapy for Neurological Disorders and Other Diseases

2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy